Navigation Links
Regenerative Medicine Appoints Cell Therapy Group Consultant to Editorial Board
Date:8/27/2008

Cell therapy industry consultant Lee Buckler appointed to Regenerative Medicine editorial board.

Vancouver, BC (PRWEB) August 27, 2008 -- The Cell Therapy Group (www.celltherapygroup.com) announced today the appointment of its principle consultant, R. Lee Buckler, to the Editorial Board of the journal Regenerative Medicine.

Published by Future Medicine, Regenerative Medicine has become a premier journal for a fast growing community of specialists addressing the important challenges and advances in the commercializing of cell therapy research and regenerative medicine.

Under the aegis of Dr. Chris Mason who heads the Regenerative Medicine Bioprocess Group in the Advanced Centre for Biochemical Engineering at University College London (UCL), the journal features an editorial board of over 70 leading international experts drawn from the leading forces in industry and academia.

Mr. Buckler has served many capacities in the regenerative medicine sector to-date including Executive Director of the International Society for Cellular Therapy (ISCT), Operations Manager of Malachite Management, Founder and Editor-in-Chief of Cell Therapy News, business development and marketing communications at Progenitor Cell Therapy and DomaniCell, and communications at Amorcyte, Inc. Lee also served on the Editorial Advisory Board of BioProcess International. Lee heads business and commercial consulting services at the Cell Therapy Group and also blogs at http://www.celltherapyblog.com [CellTherapyBlog.com __title__ Cell Therapy Blog].

"I am pleased to have an opportunity to contribute in this way," says Lee, "to an industry poised - I believe in the short term - to bring significant, new therapeutic and commercial successes to market. The journal, Regenerative Medicine, in addition to great science offers a unique focus on commercialization and industry challenges that will be critical to the success of this field. It is on those issues for the cell therapy sector that I look to contribute to the journal and the industry as a whole."

the Cell Therapy Group
Cell Therapy Group (CTG) is a consultancy for the commercial side of the cell therapy and regenerative medicine sector serving therapeutic, device, and reagent companies, investors, publishers, and other consultants with marketing, communications, business development, market analysis & research, management, strategic planning and other types of services related to the commercialization of cell therapies, regenerative medicine products, and ancillary support products and services. For more information, see http://www.celltherapygroup.com [CellTherapyGroup.com __title__ Cell Therapy Group Website].

Regenerative Medicine
Indexed on MEDLINE and ISI Science Citation Index, Regenerative Medicine was recently recognized by The Association of Learned and Professional Society Publishers as joint winner of the 2006 ALPSP/Charlesworth Award for Best New Journal. This prestigious international award is presented annually to the best new journal across a wide range of disciplines. For more info, see www.futuremedicine.com/loi/rme.

###

Read the full story at http://www.prweb.com/releases/2008/08/prweb1246204.htm


'/>"/>
Source: PRWeb
Copyright©2008 Vocus, Inc.
All rights reserved  

Related biology technology :

1. CryoLife to Present at Bear Stearns Healthcare and First Albany Capitals Regenerative Technologies Conferences in New York
2. MUSC Spin-Off Company to Test Regenerative Wound Healing Gel
3. NeoStems Denis Rodgerson, Ph.D. to Lecture on Stem Cells and Regenerative Medicine at University of Nevada Las Vegas Campus
4. Organogenesis, Inc. to Develop Regenerative Medicine Therapies for U.S. Military Battlefield Injuries
5. Osteotechs Plexur(R) Technology to Be Used in Craniofacial Reconstruction Program Funded by the Armed Forces Institute of Regenerative Medicine
6. The Gladstone Institutes and iZumi Bio Announce Broad Partnership in Regenerative Medicine and Cardiovascular Disease
7. Center for Molecular Medicine Only Regional Provider of Test Suggested in FDA Alert on Prescribing Codeine to Nursing Mothers
8. Systems Medicine (SM), a Subsidiary of Cell Therapeutics, Inc. (CTI), Announces Execution of CRADA with NCI/NIH to Develop Potential Cancer Treatments Targeting the Insulin Growth Factor (IGF) Pathway
9. The 3rd Annual Burrill Personalized Medicine Meeting November 12-13, 2007 in San Francisco
10. Pharmion and MethylGene Announce Orphan Drug Designation Granted by the European Medicines Agency (EMEA) for MGCD0103 for the Treatment of Hodgkins Lymphoma
11. Agendia Joins the Personalized Medicine Coalition (PMC)
Post Your Comments:
*Name:
*Comment:
*Email:
Related Image:
Regenerative Medicine Appoints Cell Therapy Group Consultant to Editorial Board
(Date:10/12/2017)... ... October 12, 2017 , ... BioMedGPS announces expanded coverage of ... newest module, US Hemostats & Sealants. , SmartTRAK’s US Market for Hemostats and ... synthetic sealants and biologic sealants used in surgical applications. BioMedGPS estimates the market ...
(Date:10/12/2017)... CA (PRWEB) , ... October ... ... (https://www.onramp.bio/ ) has launched Rosalind™, the first-ever genomics analysis platform specifically designed ... bioinformatics complexity. Named in honor of pioneering researcher Rosalind Franklin, who made ...
(Date:10/11/2017)... CA (PRWEB) , ... October 11, 2017 , ... ... upregulate any gene in its endogenous context, enabling overexpression experiments and avoiding the ... system with small RNA guides is transformative for performing systematic gain-of-function studies. ...
(Date:10/11/2017)... USA (PRWEB) , ... October 11, 2017 , ... ComplianceOnline’s ... take place on 7th and 8th June 2018 in San Francisco, CA. The Summit ... as well as several distinguished CEOs, board directors and government officials from around the ...
Breaking Biology Technology:
(Date:4/11/2017)... 11, 2017 Crossmatch®, a globally-recognized leader ... today announced that it has been awarded a ... Activity (IARPA) to develop next-generation Presentation Attack Detection ... "Innovation has been a driving force within Crossmatch ... allow us to innovate and develop new technologies ...
(Date:4/6/2017)... 6, 2017 Forecasts by Product ... Readers, by End-Use (Transportation & Logistics, Government & Public ... & Fossil Generation Facility, Nuclear Power), Industrial, Retail, Business ... Are you looking for a definitive report on ... ...
(Date:4/4/2017)... NEW YORK , April 4, 2017   ... solutions, today announced that the United States Patent and ... The patent broadly covers the linking of an iris ... the same transaction) and represents the company,s 45 th ... our latest patent is very timely given the multi-modal ...
Breaking Biology News(10 mins):